nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—CYP2A6—prostate cancer	0.0067	0.351	CrCbGaD
Nabilone—Dronabinol—CYP2C19—prostate cancer	0.00471	0.247	CrCbGaD
Nabilone—Dronabinol—CYP1A1—prostate cancer	0.0047	0.246	CrCbGaD
Nabilone—Dronabinol—CYP3A4—prostate cancer	0.003	0.157	CrCbGaD
Nabilone—CNR1—prostate gland—prostate cancer	0.000623	0.568	CbGeAlD
Nabilone—CNR2—Signaling Pathways—GHR—prostate cancer	0.000404	0.00148	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PRKCQ—prostate cancer	0.000399	0.00146	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTHLH—prostate cancer	0.000399	0.00146	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL12—prostate cancer	0.000397	0.00145	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JUP—prostate cancer	0.00039	0.00143	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—WNT4—prostate cancer	0.00039	0.00143	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRP1—prostate cancer	0.000387	0.00142	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRB2—prostate cancer	0.000375	0.00137	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ANXA1—prostate cancer	0.000375	0.00137	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RALBP1—prostate cancer	0.000372	0.00136	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MC2R—prostate cancer	0.000372	0.00136	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—VAV3—prostate cancer	0.000366	0.00134	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PRKCQ—prostate cancer	0.000362	0.00133	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTHLH—prostate cancer	0.000362	0.00133	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VIP—prostate cancer	0.00036	0.00132	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNRH1—prostate cancer	0.00036	0.00132	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ITPR1—prostate cancer	0.000355	0.0013	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PRKACB—prostate cancer	0.000354	0.0013	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CALCA—prostate cancer	0.000351	0.00129	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LPAR1—prostate cancer	0.000348	0.00128	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRP—prostate cancer	0.000348	0.00128	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PPP3CA—prostate cancer	0.000345	0.00127	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLCB2—prostate cancer	0.000345	0.00126	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LRP2—prostate cancer	0.000345	0.00126	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL12—prostate cancer	0.000343	0.00126	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRB2—prostate cancer	0.00034	0.00125	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ANXA1—prostate cancer	0.00034	0.00125	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CX3CL1—prostate cancer	0.000338	0.00124	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—P4HB—prostate cancer	0.000338	0.00124	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—VAV3—prostate cancer	0.000332	0.00122	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PENK—prostate cancer	0.000332	0.00122	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIST1H2BG—prostate cancer	0.000332	0.00122	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.00033	0.00121	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRB7—prostate cancer	0.000329	0.00121	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDE4D—prostate cancer	0.000329	0.00121	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ITPR1—prostate cancer	0.000322	0.00118	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIST1H4H—prostate cancer	0.000321	0.00117	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—prostate cancer	0.00032	0.00117	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CALCA—prostate cancer	0.000319	0.00117	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—AKT1—prostate cancer	0.000318	0.00117	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GHR—prostate cancer	0.000317	0.00116	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNG5—prostate cancer	0.000313	0.00115	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000313	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL12—prostate cancer	0.000311	0.00114	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRP1—prostate cancer	0.000304	0.00111	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRB2—prostate cancer	0.000294	0.00108	CbGpPWpGaD
Nabilone—Vision blurred—Prednisone—prostate cancer	0.000289	0.000408	CcSEcCtD
Nabilone—Infection—Docetaxel—prostate cancer	0.000288	0.000407	CcSEcCtD
Nabilone—Feeling abnormal—Etoposide—prostate cancer	0.000287	0.000406	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—VAV3—prostate cancer	0.000287	0.00105	CbGpPWpGaD
Nabilone—Diarrhoea—Mitoxantrone—prostate cancer	0.000287	0.000406	CcSEcCtD
Nabilone—Dry mouth—Capecitabine—prostate cancer	0.000286	0.000405	CcSEcCtD
Nabilone—Vomiting—Estradiol—prostate cancer	0.000286	0.000405	CcSEcCtD
Nabilone—Gastrointestinal pain—Etoposide—prostate cancer	0.000285	0.000403	CcSEcCtD
Nabilone—Shock—Docetaxel—prostate cancer	0.000285	0.000403	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PRKCQ—prostate cancer	0.000284	0.00104	CbGpPWpGaD
Nabilone—Ill-defined disorder—Prednisone—prostate cancer	0.000284	0.000402	CcSEcCtD
Nabilone—Rash—Estradiol—prostate cancer	0.000284	0.000401	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—prostate cancer	0.000284	0.000401	CcSEcCtD
Nabilone—Dermatitis—Estradiol—prostate cancer	0.000283	0.000401	CcSEcCtD
Nabilone—Anaemia—Prednisone—prostate cancer	0.000283	0.0004	CcSEcCtD
Nabilone—Confusional state—Capecitabine—prostate cancer	0.000283	0.0004	CcSEcCtD
Nabilone—Tachycardia—Docetaxel—prostate cancer	0.000283	0.0004	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GNRH1—prostate cancer	0.000282	0.00103	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VIP—prostate cancer	0.000282	0.00103	CbGpPWpGaD
Nabilone—Headache—Estradiol—prostate cancer	0.000282	0.000399	CcSEcCtD
Nabilone—Agitation—Prednisone—prostate cancer	0.000281	0.000398	CcSEcCtD
Nabilone—Infection—Capecitabine—prostate cancer	0.000279	0.000394	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—ITPR1—prostate cancer	0.000278	0.00102	CbGpPWpGaD
Nabilone—Stomatitis—Doxorubicin—prostate cancer	0.000276	0.000391	CcSEcCtD
Nabilone—Anorexia—Docetaxel—prostate cancer	0.000276	0.000391	CcSEcCtD
Nabilone—Malaise—Prednisone—prostate cancer	0.000276	0.000391	CcSEcCtD
Nabilone—Shock—Capecitabine—prostate cancer	0.000276	0.00039	CcSEcCtD
Nabilone—Abdominal pain—Etoposide—prostate cancer	0.000276	0.00039	CcSEcCtD
Nabilone—Body temperature increased—Etoposide—prostate cancer	0.000276	0.00039	CcSEcCtD
Nabilone—Vertigo—Prednisone—prostate cancer	0.000275	0.000389	CcSEcCtD
Nabilone—Syncope—Prednisone—prostate cancer	0.000275	0.000388	CcSEcCtD
Nabilone—CNR1—testis—prostate cancer	0.000274	0.25	CbGeAlD
Nabilone—Tachycardia—Capecitabine—prostate cancer	0.000274	0.000387	CcSEcCtD
Nabilone—Hypoaesthesia—Epirubicin—prostate cancer	0.000274	0.000387	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GRP—prostate cancer	0.000273	0.001	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LPAR1—prostate cancer	0.000273	0.001	CbGpPWpGaD
Nabilone—Pharyngitis—Epirubicin—prostate cancer	0.000273	0.000386	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TGFBR1—prostate cancer	0.000273	0.000999	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTHLH—prostate cancer	0.000273	0.000999	CbGpPWpGaD
Nabilone—Hyperhidrosis—Capecitabine—prostate cancer	0.000271	0.000384	CcSEcCtD
Nabilone—Hypotension—Docetaxel—prostate cancer	0.000271	0.000383	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PLCB2—prostate cancer	0.000271	0.000992	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LRP2—prostate cancer	0.000271	0.000992	CbGpPWpGaD
Nabilone—Loss of consciousness—Prednisone—prostate cancer	0.000269	0.000381	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—AKR1C3—prostate cancer	0.000268	0.000983	CbGpPWpGaD
Nabilone—Epistaxis—Doxorubicin—prostate cancer	0.000267	0.000378	CcSEcCtD
Nabilone—Anorexia—Capecitabine—prostate cancer	0.000267	0.000378	CcSEcCtD
Nabilone—Nausea—Estradiol—prostate cancer	0.000267	0.000378	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ADRB2—prostate cancer	0.000267	0.000979	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKACB—prostate cancer	0.000267	0.000977	CbGpPWpGaD
Nabilone—Vomiting—Mitoxantrone—prostate cancer	0.000267	0.000377	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CX3CL1—prostate cancer	0.000265	0.000972	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—P4HB—prostate cancer	0.000265	0.000972	CbGpPWpGaD
Nabilone—Convulsion—Prednisone—prostate cancer	0.000265	0.000375	CcSEcCtD
Nabilone—Visual impairment—Epirubicin—prostate cancer	0.000265	0.000375	CcSEcCtD
Nabilone—Hypertension—Prednisone—prostate cancer	0.000264	0.000374	CcSEcCtD
Nabilone—Rash—Mitoxantrone—prostate cancer	0.000264	0.000374	CcSEcCtD
Nabilone—Dermatitis—Mitoxantrone—prostate cancer	0.000264	0.000374	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000264	0.000373	CcSEcCtD
Nabilone—Headache—Mitoxantrone—prostate cancer	0.000263	0.000371	CcSEcCtD
Nabilone—Hypotension—Capecitabine—prostate cancer	0.000262	0.000371	CcSEcCtD
Nabilone—Insomnia—Docetaxel—prostate cancer	0.000262	0.000371	CcSEcCtD
Nabilone—Myalgia—Prednisone—prostate cancer	0.000261	0.000369	CcSEcCtD
Nabilone—Arthralgia—Prednisone—prostate cancer	0.000261	0.000369	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—VAV3—prostate cancer	0.000261	0.000955	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000261	0.000954	CbGpPWpGaD
Nabilone—Paraesthesia—Docetaxel—prostate cancer	0.00026	0.000368	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—THBS1—prostate cancer	0.00026	0.000953	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PPP3CA—prostate cancer	0.00026	0.000953	CbGpPWpGaD
Nabilone—Anxiety—Prednisone—prostate cancer	0.00026	0.000368	CcSEcCtD
Nabilone—Dyspnoea—Docetaxel—prostate cancer	0.000258	0.000365	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GRB7—prostate cancer	0.000258	0.000946	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDE4D—prostate cancer	0.000258	0.000946	CbGpPWpGaD
Nabilone—Somnolence—Docetaxel—prostate cancer	0.000258	0.000364	CcSEcCtD
Nabilone—Discomfort—Prednisone—prostate cancer	0.000258	0.000364	CcSEcCtD
Nabilone—Eye disorder—Epirubicin—prostate cancer	0.000257	0.000364	CcSEcCtD
Nabilone—Hypersensitivity—Etoposide—prostate cancer	0.000257	0.000363	CcSEcCtD
Nabilone—Tinnitus—Epirubicin—prostate cancer	0.000256	0.000363	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ANXA1—prostate cancer	0.000256	0.000939	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000256	0.000362	CcSEcCtD
Nabilone—Flushing—Epirubicin—prostate cancer	0.000255	0.000361	CcSEcCtD
Nabilone—Dyspepsia—Docetaxel—prostate cancer	0.000255	0.000361	CcSEcCtD
Nabilone—Insomnia—Capecitabine—prostate cancer	0.000254	0.000359	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—prostate cancer	0.000253	0.000358	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ITPR1—prostate cancer	0.000253	0.000926	CbGpPWpGaD
Nabilone—Pharyngitis—Doxorubicin—prostate cancer	0.000253	0.000357	CcSEcCtD
Nabilone—Paraesthesia—Capecitabine—prostate cancer	0.000252	0.000356	CcSEcCtD
Nabilone—Decreased appetite—Docetaxel—prostate cancer	0.000252	0.000356	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PRKCZ—prostate cancer	0.000252	0.000922	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIST1H4H—prostate cancer	0.000252	0.000922	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—prostate cancer	0.000251	0.000921	CbGpPWpGaD
Nabilone—Asthenia—Etoposide—prostate cancer	0.00025	0.000354	CcSEcCtD
Nabilone—Dyspnoea—Capecitabine—prostate cancer	0.00025	0.000354	CcSEcCtD
Nabilone—Fatigue—Docetaxel—prostate cancer	0.00025	0.000353	CcSEcCtD
Nabilone—Nausea—Mitoxantrone—prostate cancer	0.000249	0.000352	CcSEcCtD
Nabilone—Infection—Prednisone—prostate cancer	0.000248	0.000351	CcSEcCtD
Nabilone—Pain—Docetaxel—prostate cancer	0.000248	0.000351	CcSEcCtD
Nabilone—Constipation—Docetaxel—prostate cancer	0.000248	0.000351	CcSEcCtD
Nabilone—Dyspepsia—Capecitabine—prostate cancer	0.000247	0.000349	CcSEcCtD
Nabilone—Chills—Epirubicin—prostate cancer	0.000247	0.000349	CcSEcCtD
Nabilone—Pruritus—Etoposide—prostate cancer	0.000247	0.000349	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—prostate cancer	0.000246	0.000901	CbGpPWpGaD
Nabilone—Shock—Prednisone—prostate cancer	0.000246	0.000348	CcSEcCtD
Nabilone—Arrhythmia—Epirubicin—prostate cancer	0.000246	0.000348	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GNG5—prostate cancer	0.000246	0.0009	CbGpPWpGaD
Nabilone—Visual impairment—Doxorubicin—prostate cancer	0.000245	0.000347	CcSEcCtD
Nabilone—Tachycardia—Prednisone—prostate cancer	0.000244	0.000345	CcSEcCtD
Nabilone—Decreased appetite—Capecitabine—prostate cancer	0.000244	0.000345	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PARP1—prostate cancer	0.000243	0.00089	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGFR4—prostate cancer	0.000243	0.00089	CbGpPWpGaD
Nabilone—Fatigue—Capecitabine—prostate cancer	0.000242	0.000342	CcSEcCtD
Nabilone—Hyperhidrosis—Prednisone—prostate cancer	0.000242	0.000342	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CALCA—prostate cancer	0.00024	0.000879	CbGpPWpGaD
Nabilone—Pain—Capecitabine—prostate cancer	0.00024	0.000339	CcSEcCtD
Nabilone—Constipation—Capecitabine—prostate cancer	0.00024	0.000339	CcSEcCtD
Nabilone—Feeling abnormal—Docetaxel—prostate cancer	0.000239	0.000338	CcSEcCtD
Nabilone—Diarrhoea—Etoposide—prostate cancer	0.000239	0.000337	CcSEcCtD
Nabilone—Anorexia—Prednisone—prostate cancer	0.000238	0.000337	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—prostate cancer	0.000238	0.000337	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—prostate cancer	0.000237	0.000336	CcSEcCtD
Nabilone—Gastrointestinal pain—Docetaxel—prostate cancer	0.000237	0.000335	CcSEcCtD
Nabilone—Flushing—Doxorubicin—prostate cancer	0.000236	0.000334	CcSEcCtD
Nabilone—Tension—Epirubicin—prostate cancer	0.000235	0.000332	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CXCL12—prostate cancer	0.000234	0.000859	CbGpPWpGaD
Nabilone—Nervousness—Epirubicin—prostate cancer	0.000233	0.000329	CcSEcCtD
Nabilone—Back pain—Epirubicin—prostate cancer	0.000232	0.000328	CcSEcCtD
Nabilone—Feeling abnormal—Capecitabine—prostate cancer	0.000231	0.000327	CcSEcCtD
Nabilone—Dizziness—Etoposide—prostate cancer	0.000231	0.000326	CcSEcCtD
Nabilone—Gastrointestinal pain—Capecitabine—prostate cancer	0.000229	0.000325	CcSEcCtD
Nabilone—Body temperature increased—Docetaxel—prostate cancer	0.000229	0.000324	CcSEcCtD
Nabilone—Abdominal pain—Docetaxel—prostate cancer	0.000229	0.000324	CcSEcCtD
Nabilone—Chills—Doxorubicin—prostate cancer	0.000228	0.000323	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000228	0.000322	CcSEcCtD
Nabilone—Arrhythmia—Doxorubicin—prostate cancer	0.000227	0.000322	CcSEcCtD
Nabilone—Insomnia—Prednisone—prostate cancer	0.000226	0.00032	CcSEcCtD
Nabilone—Vision blurred—Epirubicin—prostate cancer	0.000226	0.000319	CcSEcCtD
Nabilone—Paraesthesia—Prednisone—prostate cancer	0.000224	0.000317	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—prostate cancer	0.000223	0.000818	CbGpPWpGaD
Nabilone—Ill-defined disorder—Epirubicin—prostate cancer	0.000222	0.000314	CcSEcCtD
Nabilone—Abdominal pain—Capecitabine—prostate cancer	0.000222	0.000314	CcSEcCtD
Nabilone—Body temperature increased—Capecitabine—prostate cancer	0.000222	0.000314	CcSEcCtD
Nabilone—Vomiting—Etoposide—prostate cancer	0.000222	0.000314	CcSEcCtD
Nabilone—Anaemia—Epirubicin—prostate cancer	0.000221	0.000313	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CASP9—prostate cancer	0.000221	0.000809	CbGpPWpGaD
Nabilone—Agitation—Epirubicin—prostate cancer	0.00022	0.000311	CcSEcCtD
Nabilone—Dyspepsia—Prednisone—prostate cancer	0.00022	0.000311	CcSEcCtD
Nabilone—Rash—Etoposide—prostate cancer	0.00022	0.000311	CcSEcCtD
Nabilone—Dermatitis—Etoposide—prostate cancer	0.00022	0.000311	CcSEcCtD
Nabilone—Headache—Etoposide—prostate cancer	0.000218	0.000309	CcSEcCtD
Nabilone—Tension—Doxorubicin—prostate cancer	0.000217	0.000308	CcSEcCtD
Nabilone—Decreased appetite—Prednisone—prostate cancer	0.000217	0.000307	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CD—prostate cancer	0.000216	0.000792	CbGpPWpGaD
Nabilone—Malaise—Epirubicin—prostate cancer	0.000216	0.000306	CcSEcCtD
Nabilone—Fatigue—Prednisone—prostate cancer	0.000215	0.000305	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—prostate cancer	0.000215	0.000304	CcSEcCtD
Nabilone—Vertigo—Epirubicin—prostate cancer	0.000215	0.000304	CcSEcCtD
Nabilone—Syncope—Epirubicin—prostate cancer	0.000215	0.000304	CcSEcCtD
Nabilone—Leukopenia—Epirubicin—prostate cancer	0.000214	0.000303	CcSEcCtD
Nabilone—Back pain—Doxorubicin—prostate cancer	0.000214	0.000303	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PRKCQ—prostate cancer	0.000214	0.000784	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NGFR—prostate cancer	0.000214	0.000784	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTHLH—prostate cancer	0.000214	0.000784	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFBR1—prostate cancer	0.000214	0.000784	CbGpPWpGaD
Nabilone—Constipation—Prednisone—prostate cancer	0.000214	0.000302	CcSEcCtD
Nabilone—Hypersensitivity—Docetaxel—prostate cancer	0.000213	0.000302	CcSEcCtD
Nabilone—Palpitations—Epirubicin—prostate cancer	0.000212	0.000299	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MAP3K7—prostate cancer	0.000211	0.000774	CbGpPWpGaD
Nabilone—Loss of consciousness—Epirubicin—prostate cancer	0.00021	0.000298	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—AKR1C3—prostate cancer	0.00021	0.000771	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKACB—prostate cancer	0.000209	0.000767	CbGpPWpGaD
Nabilone—Cough—Epirubicin—prostate cancer	0.000209	0.000296	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—prostate cancer	0.000209	0.000295	CcSEcCtD
Nabilone—Asthenia—Docetaxel—prostate cancer	0.000208	0.000294	CcSEcCtD
Nabilone—Convulsion—Epirubicin—prostate cancer	0.000207	0.000294	CcSEcCtD
Nabilone—Nausea—Etoposide—prostate cancer	0.000207	0.000293	CcSEcCtD
Nabilone—Hypertension—Epirubicin—prostate cancer	0.000207	0.000292	CcSEcCtD
Nabilone—Hypersensitivity—Capecitabine—prostate cancer	0.000207	0.000292	CcSEcCtD
Nabilone—Feeling abnormal—Prednisone—prostate cancer	0.000206	0.000291	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—prostate cancer	0.000206	0.000291	CcSEcCtD
Nabilone—Pruritus—Docetaxel—prostate cancer	0.000205	0.00029	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—prostate cancer	0.000205	0.00029	CcSEcCtD
Nabilone—Gastrointestinal pain—Prednisone—prostate cancer	0.000204	0.000289	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PPP3CA—prostate cancer	0.000204	0.000748	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—THBS1—prostate cancer	0.000204	0.000748	CbGpPWpGaD
Nabilone—Chest pain—Epirubicin—prostate cancer	0.000204	0.000288	CcSEcCtD
Nabilone—Myalgia—Epirubicin—prostate cancer	0.000204	0.000288	CcSEcCtD
Nabilone—Arthralgia—Epirubicin—prostate cancer	0.000204	0.000288	CcSEcCtD
Nabilone—Agitation—Doxorubicin—prostate cancer	0.000204	0.000288	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGF10—prostate cancer	0.000203	0.000745	CbGpPWpGaD
Nabilone—Anxiety—Epirubicin—prostate cancer	0.000203	0.000287	CcSEcCtD
Nabilone—Discomfort—Epirubicin—prostate cancer	0.000201	0.000285	CcSEcCtD
Nabilone—Asthenia—Capecitabine—prostate cancer	0.000201	0.000285	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADRB2—prostate cancer	0.000201	0.000737	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ANXA1—prostate cancer	0.000201	0.000737	CbGpPWpGaD
Nabilone—Malaise—Doxorubicin—prostate cancer	0.0002	0.000283	CcSEcCtD
Nabilone—Dry mouth—Epirubicin—prostate cancer	0.000199	0.000282	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—prostate cancer	0.000199	0.000282	CcSEcCtD
Nabilone—CNR1—lymph node—prostate cancer	0.000199	0.181	CbGeAlD
Nabilone—Syncope—Doxorubicin—prostate cancer	0.000199	0.000281	CcSEcCtD
Nabilone—Pruritus—Capecitabine—prostate cancer	0.000198	0.000281	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—JAK2—prostate cancer	0.000198	0.000727	CbGpPWpGaD
Nabilone—Leukopenia—Doxorubicin—prostate cancer	0.000198	0.000281	CcSEcCtD
Nabilone—Diarrhoea—Docetaxel—prostate cancer	0.000198	0.00028	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MAP2K1—prostate cancer	0.000198	0.000724	CbGpPWpGaD
Nabilone—Abdominal pain—Prednisone—prostate cancer	0.000198	0.000279	CcSEcCtD
Nabilone—Body temperature increased—Prednisone—prostate cancer	0.000198	0.000279	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PRKCZ—prostate cancer	0.000197	0.000723	CbGpPWpGaD
Nabilone—Confusional state—Epirubicin—prostate cancer	0.000197	0.000279	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CD—prostate cancer	0.000196	0.000719	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VAV3—prostate cancer	0.000196	0.000719	CbGpPWpGaD
Nabilone—Palpitations—Doxorubicin—prostate cancer	0.000196	0.000277	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—prostate cancer	0.000195	0.000276	CcSEcCtD
Nabilone—Infection—Epirubicin—prostate cancer	0.000194	0.000275	CcSEcCtD
Nabilone—Cough—Doxorubicin—prostate cancer	0.000193	0.000274	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TGFBR2—prostate cancer	0.000193	0.000708	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—prostate cancer	0.000193	0.000707	CbGpPWpGaD
Nabilone—Shock—Epirubicin—prostate cancer	0.000192	0.000272	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—prostate cancer	0.000192	0.000272	CcSEcCtD
Nabilone—Diarrhoea—Capecitabine—prostate cancer	0.000192	0.000272	CcSEcCtD
Nabilone—Dizziness—Docetaxel—prostate cancer	0.000192	0.000271	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—prostate cancer	0.000191	0.000271	CcSEcCtD
Nabilone—Tachycardia—Epirubicin—prostate cancer	0.000191	0.00027	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PARP1—prostate cancer	0.000191	0.000699	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGFR4—prostate cancer	0.000191	0.000699	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ITPR1—prostate cancer	0.00019	0.000697	CbGpPWpGaD
Nabilone—Hyperhidrosis—Epirubicin—prostate cancer	0.000189	0.000267	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—prostate cancer	0.000189	0.000267	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—prostate cancer	0.000189	0.000267	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—prostate cancer	0.000189	0.000267	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CB—prostate cancer	0.000188	0.00069	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CALCA—prostate cancer	0.000188	0.00069	CbGpPWpGaD
Nabilone—Anxiety—Doxorubicin—prostate cancer	0.000188	0.000266	CcSEcCtD
Nabilone—Discomfort—Doxorubicin—prostate cancer	0.000186	0.000264	CcSEcCtD
Nabilone—Anorexia—Epirubicin—prostate cancer	0.000186	0.000264	CcSEcCtD
Nabilone—Dizziness—Capecitabine—prostate cancer	0.000186	0.000262	CcSEcCtD
Nabilone—Dry mouth—Doxorubicin—prostate cancer	0.000184	0.000261	CcSEcCtD
Nabilone—Vomiting—Docetaxel—prostate cancer	0.000184	0.000261	CcSEcCtD
Nabilone—Hypersensitivity—Prednisone—prostate cancer	0.000184	0.00026	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CXCL12—prostate cancer	0.000184	0.000674	CbGpPWpGaD
Nabilone—Rash—Docetaxel—prostate cancer	0.000183	0.000258	CcSEcCtD
Nabilone—Hypotension—Epirubicin—prostate cancer	0.000183	0.000258	CcSEcCtD
Nabilone—Dermatitis—Docetaxel—prostate cancer	0.000183	0.000258	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—prostate cancer	0.000182	0.000258	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IGF1R—prostate cancer	0.000182	0.000666	CbGpPWpGaD
Nabilone—Headache—Docetaxel—prostate cancer	0.000182	0.000257	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—prostate cancer	0.000181	0.000663	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—JAK2—prostate cancer	0.00018	0.00066	CbGpPWpGaD
Nabilone—Infection—Doxorubicin—prostate cancer	0.00018	0.000254	CcSEcCtD
Nabilone—Asthenia—Prednisone—prostate cancer	0.000179	0.000254	CcSEcCtD
Nabilone—Vomiting—Capecitabine—prostate cancer	0.000178	0.000252	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000178	0.000252	CcSEcCtD
Nabilone—Shock—Doxorubicin—prostate cancer	0.000178	0.000252	CcSEcCtD
Nabilone—Rash—Capecitabine—prostate cancer	0.000177	0.00025	CcSEcCtD
Nabilone—Pruritus—Prednisone—prostate cancer	0.000177	0.00025	CcSEcCtD
Nabilone—Insomnia—Epirubicin—prostate cancer	0.000177	0.00025	CcSEcCtD
Nabilone—Dermatitis—Capecitabine—prostate cancer	0.000177	0.00025	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—prostate cancer	0.000176	0.00025	CcSEcCtD
Nabilone—Headache—Capecitabine—prostate cancer	0.000176	0.000249	CcSEcCtD
Nabilone—Paraesthesia—Epirubicin—prostate cancer	0.000175	0.000248	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—prostate cancer	0.000175	0.000642	CbGpPWpGaD
Nabilone—Hyperhidrosis—Doxorubicin—prostate cancer	0.000175	0.000247	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—LPL—prostate cancer	0.000174	0.000639	CbGpPWpGaD
Nabilone—Dyspnoea—Epirubicin—prostate cancer	0.000174	0.000247	CcSEcCtD
Nabilone—Somnolence—Epirubicin—prostate cancer	0.000174	0.000246	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CASP9—prostate cancer	0.000173	0.000635	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IL2—prostate cancer	0.000173	0.000634	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFRB—prostate cancer	0.000173	0.000633	CbGpPWpGaD
Nabilone—Anorexia—Doxorubicin—prostate cancer	0.000172	0.000244	CcSEcCtD
Nabilone—Nausea—Docetaxel—prostate cancer	0.000172	0.000243	CcSEcCtD
Nabilone—Dyspepsia—Epirubicin—prostate cancer	0.000172	0.000243	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CB—prostate cancer	0.000171	0.000627	CbGpPWpGaD
Nabilone—Diarrhoea—Prednisone—prostate cancer	0.000171	0.000242	CcSEcCtD
Nabilone—Decreased appetite—Epirubicin—prostate cancer	0.00017	0.00024	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CD—prostate cancer	0.00017	0.000622	CbGpPWpGaD
Nabilone—Hypotension—Doxorubicin—prostate cancer	0.000169	0.000239	CcSEcCtD
Nabilone—Fatigue—Epirubicin—prostate cancer	0.000168	0.000238	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ITGB3—prostate cancer	0.000168	0.000617	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKCQ—prostate cancer	0.000168	0.000615	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NGFR—prostate cancer	0.000168	0.000615	CbGpPWpGaD
Nabilone—Constipation—Epirubicin—prostate cancer	0.000167	0.000236	CcSEcCtD
Nabilone—Pain—Epirubicin—prostate cancer	0.000167	0.000236	CcSEcCtD
Nabilone—Nausea—Capecitabine—prostate cancer	0.000167	0.000236	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—MAP3K7—prostate cancer	0.000166	0.000608	CbGpPWpGaD
Nabilone—Dizziness—Prednisone—prostate cancer	0.000165	0.000234	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000165	0.000233	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CXCL8—prostate cancer	0.000164	0.000602	CbGpPWpGaD
Nabilone—Insomnia—Doxorubicin—prostate cancer	0.000164	0.000231	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ERBB3—prostate cancer	0.000163	0.000599	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGFR2—prostate cancer	0.000163	0.000598	CbGpPWpGaD
Nabilone—Paraesthesia—Doxorubicin—prostate cancer	0.000162	0.00023	CcSEcCtD
Nabilone—Dyspnoea—Doxorubicin—prostate cancer	0.000161	0.000228	CcSEcCtD
Nabilone—Feeling abnormal—Epirubicin—prostate cancer	0.000161	0.000228	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—prostate cancer	0.000161	0.000227	CcSEcCtD
Nabilone—Gastrointestinal pain—Epirubicin—prostate cancer	0.00016	0.000226	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGF10—prostate cancer	0.00016	0.000584	CbGpPWpGaD
Nabilone—Dyspepsia—Doxorubicin—prostate cancer	0.000159	0.000225	CcSEcCtD
Nabilone—Vomiting—Prednisone—prostate cancer	0.000159	0.000225	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ADRB2—prostate cancer	0.000158	0.000578	CbGpPWpGaD
Nabilone—Rash—Prednisone—prostate cancer	0.000158	0.000223	CcSEcCtD
Nabilone—Dermatitis—Prednisone—prostate cancer	0.000157	0.000223	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—prostate cancer	0.000157	0.000222	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL2—prostate cancer	0.000157	0.000576	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TERT—prostate cancer	0.000157	0.000574	CbGpPWpGaD
Nabilone—Headache—Prednisone—prostate cancer	0.000157	0.000221	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—prostate cancer	0.000156	0.000221	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—JAK2—prostate cancer	0.000156	0.00057	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAP2K1—prostate cancer	0.000155	0.000568	CbGpPWpGaD
Nabilone—Pain—Doxorubicin—prostate cancer	0.000155	0.000219	CcSEcCtD
Nabilone—Constipation—Doxorubicin—prostate cancer	0.000155	0.000219	CcSEcCtD
Nabilone—Body temperature increased—Epirubicin—prostate cancer	0.000154	0.000219	CcSEcCtD
Nabilone—Abdominal pain—Epirubicin—prostate cancer	0.000154	0.000219	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CD—prostate cancer	0.000154	0.000564	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VAV3—prostate cancer	0.000154	0.000564	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFBR2—prostate cancer	0.000152	0.000556	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIF1A—prostate cancer	0.00015	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ITPR1—prostate cancer	0.000149	0.000547	CbGpPWpGaD
Nabilone—Feeling abnormal—Doxorubicin—prostate cancer	0.000149	0.000211	CcSEcCtD
Nabilone—Nausea—Prednisone—prostate cancer	0.000148	0.00021	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000148	0.000542	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000148	0.000209	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—LEP—prostate cancer	0.000146	0.000536	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CAV1—prostate cancer	0.000145	0.000531	CbGpPWpGaD
Nabilone—Hypersensitivity—Epirubicin—prostate cancer	0.000144	0.000204	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—KDR—prostate cancer	0.000143	0.000525	CbGpPWpGaD
Nabilone—Body temperature increased—Doxorubicin—prostate cancer	0.000143	0.000202	CcSEcCtD
Nabilone—Abdominal pain—Doxorubicin—prostate cancer	0.000143	0.000202	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—IGF1R—prostate cancer	0.000143	0.000523	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—prostate cancer	0.000142	0.000521	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—JAK2—prostate cancer	0.000141	0.000518	CbGpPWpGaD
Nabilone—Asthenia—Epirubicin—prostate cancer	0.00014	0.000198	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ESR1—prostate cancer	0.00014	0.000511	CbGpPWpGaD
Nabilone—Pruritus—Epirubicin—prostate cancer	0.000138	0.000196	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—LPL—prostate cancer	0.000137	0.000501	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BAD—prostate cancer	0.000136	0.000499	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—prostate cancer	0.000136	0.000498	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFRB—prostate cancer	0.000136	0.000497	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CB—prostate cancer	0.000134	0.000492	CbGpPWpGaD
Nabilone—Diarrhoea—Epirubicin—prostate cancer	0.000134	0.000189	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—prostate cancer	0.000133	0.000188	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ITGB3—prostate cancer	0.000132	0.000484	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—prostate cancer	0.000132	0.000483	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APC—prostate cancer	0.000132	0.000483	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGF—prostate cancer	0.00013	0.000478	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS1—prostate cancer	0.00013	0.000478	CbGpPWpGaD
Nabilone—Asthenia—Doxorubicin—prostate cancer	0.00013	0.000184	CcSEcCtD
Nabilone—Dizziness—Epirubicin—prostate cancer	0.000129	0.000183	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CXCL8—prostate cancer	0.000129	0.000473	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB3—prostate cancer	0.000128	0.00047	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGFR2—prostate cancer	0.000128	0.000469	CbGpPWpGaD
Nabilone—Pruritus—Doxorubicin—prostate cancer	0.000128	0.000181	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GSK3B—prostate cancer	0.000127	0.000464	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INS—prostate cancer	0.000125	0.000458	CbGpPWpGaD
Nabilone—Vomiting—Epirubicin—prostate cancer	0.000124	0.000176	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—prostate cancer	0.000124	0.000175	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—IL2—prostate cancer	0.000123	0.000452	CbGpPWpGaD
Nabilone—Rash—Epirubicin—prostate cancer	0.000123	0.000174	CcSEcCtD
Nabilone—Dermatitis—Epirubicin—prostate cancer	0.000123	0.000174	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TERT—prostate cancer	0.000123	0.00045	CbGpPWpGaD
Nabilone—Headache—Epirubicin—prostate cancer	0.000122	0.000173	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CREBBP—prostate cancer	0.000122	0.000448	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—prostate cancer	0.000121	0.000443	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—prostate cancer	0.00012	0.00044	CbGpPWpGaD
Nabilone—Dizziness—Doxorubicin—prostate cancer	0.00012	0.000169	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HIF1A—prostate cancer	0.000118	0.000431	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAP2K1—prostate cancer	0.000117	0.000428	CbGpPWpGaD
Nabilone—Nausea—Epirubicin—prostate cancer	0.000116	0.000164	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PIK3CD—prostate cancer	0.000116	0.000425	CbGpPWpGaD
Nabilone—Vomiting—Doxorubicin—prostate cancer	0.000115	0.000163	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—prostate cancer	0.000115	0.000421	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—prostate cancer	0.000115	0.00042	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—prostate cancer	0.000115	0.00042	CbGpPWpGaD
Nabilone—Rash—Doxorubicin—prostate cancer	0.000114	0.000161	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—prostate cancer	0.000114	0.000161	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CAV1—prostate cancer	0.000114	0.000416	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KRAS—prostate cancer	0.000114	0.000416	CbGpPWpGaD
Nabilone—Headache—Doxorubicin—prostate cancer	0.000113	0.00016	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—KDR—prostate cancer	0.000112	0.000412	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF2—prostate cancer	0.000111	0.000407	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOS3—prostate cancer	0.00011	0.000401	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ESR1—prostate cancer	0.00011	0.000401	CbGpPWpGaD
Nabilone—Nausea—Doxorubicin—prostate cancer	0.000107	0.000152	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—BAD—prostate cancer	0.000107	0.000392	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JAK2—prostate cancer	0.000106	0.00039	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—prostate cancer	0.000104	0.000382	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MDM2—prostate cancer	0.000104	0.000381	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—prostate cancer	0.000104	0.000379	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—prostate cancer	0.000104	0.000379	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—prostate cancer	0.000102	0.000375	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS1—prostate cancer	0.000102	0.000375	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGF—prostate cancer	0.000102	0.000375	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CB—prostate cancer	0.000101	0.00037	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GSK3B—prostate cancer	9.93e-05	0.000364	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INS—prostate cancer	9.8e-05	0.000359	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—prostate cancer	9.71e-05	0.000356	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CREBBP—prostate cancer	9.6e-05	0.000352	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1B—prostate cancer	9.49e-05	0.000348	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—prostate cancer	9.48e-05	0.000347	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—prostate cancer	9.43e-05	0.000346	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—prostate cancer	9.38e-05	0.000344	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—prostate cancer	9.3e-05	0.000341	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—prostate cancer	9.28e-05	0.00034	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—prostate cancer	9.24e-05	0.000338	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAP2K1—prostate cancer	9.16e-05	0.000336	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CD—prostate cancer	9.1e-05	0.000333	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—prostate cancer	9.05e-05	0.000332	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—prostate cancer	9.01e-05	0.00033	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—prostate cancer	9e-05	0.00033	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CTNNB1—prostate cancer	8.96e-05	0.000328	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—prostate cancer	8.91e-05	0.000326	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—prostate cancer	8.79e-05	0.000322	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1A—prostate cancer	8.76e-05	0.000321	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTEN—prostate cancer	8.74e-05	0.00032	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF2—prostate cancer	8.71e-05	0.000319	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOS3—prostate cancer	8.59e-05	0.000315	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—prostate cancer	8.52e-05	0.000312	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JAK2—prostate cancer	8.35e-05	0.000306	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EP300—prostate cancer	8.33e-05	0.000305	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—prostate cancer	8.19e-05	0.0003	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MDM2—prostate cancer	8.15e-05	0.000299	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SRC—prostate cancer	8.1e-05	0.000297	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—prostate cancer	8.04e-05	0.000294	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CB—prostate cancer	7.93e-05	0.000291	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—prostate cancer	7.89e-05	0.000289	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—prostate cancer	7.81e-05	0.000286	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—prostate cancer	7.62e-05	0.000279	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1B—prostate cancer	7.44e-05	0.000273	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—prostate cancer	7.36e-05	0.00027	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—prostate cancer	7.3e-05	0.000267	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—prostate cancer	7.29e-05	0.000267	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—prostate cancer	7.26e-05	0.000266	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—prostate cancer	7.25e-05	0.000266	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—prostate cancer	7.24e-05	0.000265	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—prostate cancer	7.1e-05	0.00026	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—prostate cancer	7.1e-05	0.00026	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNB1—prostate cancer	7.03e-05	0.000258	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—prostate cancer	6.89e-05	0.000253	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1A—prostate cancer	6.87e-05	0.000252	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—prostate cancer	6.85e-05	0.000251	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—prostate cancer	6.71e-05	0.000246	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—prostate cancer	6.69e-05	0.000245	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EP300—prostate cancer	6.54e-05	0.000239	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SRC—prostate cancer	6.36e-05	0.000233	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—prostate cancer	6.19e-05	0.000227	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—prostate cancer	6.16e-05	0.000226	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—prostate cancer	6.13e-05	0.000225	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—prostate cancer	5.96e-05	0.000218	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—prostate cancer	5.7e-05	0.000209	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—prostate cancer	5.68e-05	0.000208	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—prostate cancer	5.57e-05	0.000204	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—prostate cancer	5.46e-05	0.0002	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—prostate cancer	5.26e-05	0.000193	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—prostate cancer	5.03e-05	0.000184	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—prostate cancer	4.84e-05	0.000177	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—prostate cancer	4.68e-05	0.000171	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—prostate cancer	4.28e-05	0.000157	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—prostate cancer	3.95e-05	0.000145	CbGpPWpGaD
